Ophthalmology

Specialized Expertise in Ophthalmology Clinical Research

Medpace’s expertise in ophthalmology studies and consistent track record of success as a full-service CRO ensures the flexibility to adapt to the unique needs of each ophthalmology trial. Our in-house physicians are board-certified medical doctors that are embedded within the project team. This allows our doctors to be fully-involved throughout the study, providing leadership, consulting with Sponsors, training project teams, and the investigative sites to ensure our operational strategy is firmly aligned with the Sponsor’s scientific and medical objectives.

Our experience with global regulatory authorities, coupled with early planning and collaboration with Sponsors, accelerates the path to approval. Our therapeutically trained teams including clinical trial managers and program coordinators provide knowledgeable training to sites and help mitigate challenges.

Our physicians and professional staff understand the complexities of ophthalmology trials from the perspective of the Sponsor, the clinical investigator, the scientific leader, and the reviewer at the regulatory agencies. We bring these perspectives to each clinical trial that we conduct.

Medpace has extensive experience partnering with the Sponsor’s choice of vendor for ophthalmology imaging to support the needs of each ophthalmology clinical trial.

Cellular and Gene Therapy Research in Ophthalmology

With recent and promising advances in ophthalmology gene therapy clinical trials, Medpace’s deep experience in cellular and gene therapy research across multiple therapeutic areas, is beneficial for Sponsors. Our cross-specialty experience is key for managing complex ophthalmology trials. The expertise we provide to other therapeutic areas, where endpoint and sub-studies with ophthalmology may exist, is invaluable. Our expertise and lessons learned provide guidance on the complexities often involved in complex research.

Central Lab

Medpace’s central laboratories are experienced in clinical research from discovery and proof of concept through large, long-term global trials. Located in the US, Belgium, China, and Singapore, all are wholly-owned and purpose-built with state-of-the-art infrastructure.  Each location has the same testing instrumentation, follow global operating procedures, and utilize a single laboratory information system, ensuring perfect harmonization of global data.